Cargando…

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia

VEXAS syndrome stands for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. The syndrome is a combined hematological and rheumatological condition caused by a somatic mutation in the UBA1. There is an association between VEXAS and hematological conditions such as myelodysplastic syn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Austestad, Janne, Madland, Tor Magne, Sandnes, Miriam, Haslerud, Torjan Magne, Benneche, Andreas, Reikvam, Håkon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985496/ https://www.ncbi.nlm.nih.gov/pubmed/36879894 http://dx.doi.org/10.1155/2023/6551544

Ejemplares similares

Kidney Failure and Abdominal Discomfort as Initial Signs of Extramedullary Acute Myelogenous Leukemia
por: Steinfeld, Peter Ferkis, et al.
Publicado: (2021)

Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis
por: Thunestvedt, Lise Mayrin Økland, et al.
Publicado: (2022)

VEXAS syndrome with cutaneous nodules
por: Argobi, Yahya
Publicado: (2021)

Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation
por: Hemsing, Anette Lodvir, et al.
Publicado: (2021)

VEXAS syndrome
por: Grayson, Peter C., et al.
Publicado: (2021)

VEXAS-Syndrom
por: Zeeck, M., et al.
Publicado: (2022)

Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report
por: Trovik, Linn Hereide, et al.
Publicado: (2020)

VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)
por: Stubbins, Ryan J., et al.
Publicado: (2021)

Thrombosis in VEXAS syndrome
por: Oo, Thet Mon, et al.
Publicado: (2021)

VEXAS Syndrome—Review
por: Zhang, Yue, et al.
Publicado: (2023)

HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis
por: Sandnes, Miriam, et al.
Publicado: (2021)

Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature
por: Gjelberg, Hilde K., et al.
Publicado: (2023)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia
por: Soares, Thamiris Silva, et al.
Publicado: (2023)

Interstitial Granulomatous Dermatitis due to a Rare Myeloproliferative Neoplasia
por: Cases-Merida, Sandra, et al.
Publicado: (2018)

A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome
por: Pozdniakova, Helen, et al.
Publicado: (2023)

Recurrent superior orbital fissure syndrome associated with VEXAS syndrome
por: Myint, Katie, et al.
Publicado: (2023)

Hyperferritinemia—A Clinical Overview
por: Sandnes, Miriam, et al.
Publicado: (2021)

VEXAS syndrome: a diagnostic puzzle
por: Ruffer, Nikolas, et al.
Publicado: (2023)

E-learning for medical imaging specialists: introducing blended learning in a nuclear medicine specialist course
por: Haslerud, Torjan, et al.
Publicado: (2017)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

SARS-CoV-2-induced venous thromboembolism in a patient with VEXAS syndrome
por: Lucchino, Bruno, et al.
Publicado: (2023)

VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib
por: Fahmy, Lauren M., et al.
Publicado: (2023)

A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma
por: Vu, Khiem T., et al.
Publicado: (2023)

VEXAS Syndrome: A Novelty in MDS Landscape
por: Templé, Marie, et al.
Publicado: (2022)

Intrapatient competition of VEXAS syndrome and CML clones
por: Djerbi, Nadia, et al.
Publicado: (2023)

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience
por: Diarra, Ava, et al.
Publicado: (2022)

The Role of MicroRNAs in Myeloproliferative Neoplasia
por: Alizadeh, Shaban, et al.
Publicado: (2016)

Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome
por: Vitale, Antonio, et al.
Publicado: (2022)

Vexas: A new syndrome not always associated with hemopathy
por: Thomas, Benoît, et al.
Publicado: (2021)

Vasculitis associated with VEXAS syndrome: A literature review
por: Watanabe, Ryu, et al.
Publicado: (2022)

Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
por: Rabut, Audrey, et al.
Publicado: (2023)

Co-existence of myeloproliferative neoplasias and β-thalassemia with IVS-2-654 mutation—a case report
por: Wu, Cai, et al.
Publicado: (2020)

Hematopoietic Neoplasias in Horses: Myeloproliferative and Lymphoproliferative Disorders
por: MUÑOZ, Ana, et al.
Publicado: (2010)

A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm
por: Li, Peng, et al.
Publicado: (2022)

Myelodysplastic Syndrome Associated With Auto-Immune Inflammatory Disease in VEXAS Syndrome
por: Thomas, Vibha Taneja, et al.
Publicado: (2021)

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome
por: Lacombe, Valentin, et al.
Publicado: (2022)

VEXAS syndrome: a newly discovered systemic rheumatic disorder
por: Kucharz, Eugenisz J.
Publicado: (2023)

Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
por: Goyal, Amrita, et al.
Publicado: (2022)

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome—clinical presentation of a newly described somatic, autoinflammatory syndrome
por: Alhomida, Faris, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gtqub8a4s287jmj72evn7eam5c